INTCO Medical Half-Year Report 2025: Growth Driven by Five Strategic Pillars

In the ever-evolving healthcare sector, demand for safe, sustainable, and innovative medical consumables continues to rise. As a global leader and a trusted latex-free disposable gloves manufacturer, INTCO Medical has officially released its 2025 Half-Year Report. The results show strong momentum, with double-digit profit growth, solid financial resilience, and significant achievements across five strategic areas—innovation, global expansion, talent development, green manufacturing, and ESG responsibility.

Strong Financial Results Despite Market Uncertainty

Amid global economic challenges, INTCO Medical delivered stable and positive results in the first half of 2025. Operating revenue reached RMB 4.913 billion (approximately USD 675 million), up 8.9% year-on-year. Net profit attributable to shareholders grew 21.02% to RMB 710 million, highlighting improved profitability. Operating cash flow was a standout, climbing 170.15% to RMB 745 million, ensuring strong funding for ongoing R&D and international expansion. By the end of June 2025, the company’s total assets stood at RMB 39.515 billion, while shareholder equity increased by 3.5% to RMB 18.012 billion, demonstrating the company’s continued growth resilience. 

Innovation as the Core Growth Engine

Innovation remains the foundation of INTCO Medical’s competitiveness. In the first half of 2025, the company launched 37 new products covering medical consumables, protective gloves, rehabilitation equipment, and home care solutions. Key launches included Synguard TouchLite Nitrile Gloves and Syntex™ Synthetic Latex (Exam) Gloves, which offer improved comfort and protection for healthcare workers. At the consumer level, customised nitrile gloves for Sam’s Club and exclusive e-commerce home-use gloves expanded INTCO’s reach into retail markets. These innovations reinforce INTCO’s leadership as a latex-free disposable gloves manufacturer, providing diverse solutions for medical, industrial, and personal use. 

Expanding Global Reach Through Marketing and Partnerships

With its “Global INTCO, Global Health” mission, the company is enhancing both online and offline presence. Online, INTCO has built a strong presence across Instagram, Facebook, TikTok, and major e-commerce platforms such as Tmall and JD.com, creating an integrated “content + commerce” model. Offline, INTCO participated in 15 trade shows across 10 countries and regions during the first half of 2025, strengthening its relationships with international customers and boosting brand visibility worldwide. 

Talent Development: Building the Next Generation Workforce

Talent remains central to INTCO’s strategy. In 2025, the company launched its “Elite Talent Program,” starting at Tsinghua University and extending to other leading universities, creating a high-level talent pipeline. Nearly 500 graduates joined INTCO in the first half of 2025, injecting fresh perspectives into research, production, and global expansion. With the motto “Be a Better Self in 2025,” the company provides comprehensive training and career development opportunities, ensuring its workforce aligns with global ambitions. 

Green Manufacturing and Sustainability Leadership

INTCO Medical is committed to sustainable growth in alignment with China’s “dual carbon” strategy. In 2025, its nitrile and PVC gloves both received dual LCA (Life Cycle Assessment) and carbon footprint certifications, making INTCO the first domestic glove manufacturer to achieve this milestone. These certifications comply with international sustainability benchmarks such as EPA Sustainable Materials Management and the European Commission Product Environmental Footprint Guidelines.

Additionally, the Anhui wind power project was successfully connected to the grid, expected to save 6,246.5 tons of standard coal and reduce 17,154.5 tons of carbon dioxide emissions annually. These achievements demonstrate INTCO’s role as a benchmark for ESG practices, ensuring green production while expanding its leadership as a latex-free disposable gloves manufacturer.

ESG Responsibility and Social Commitment

INTCO’s strong ESG performance has been widely recognised. In the first half of 2025, the company won multiple honours, including the 2025 “Golden Antelope ESG Annual Model Enterprise” award and the “Silver Persimmon ESG Excellence Award.” Its disposable nitrile gloves were also named a “Jiangxi Famous Brand Product,” underscoring growing brand influence.

On the social responsibility front, by July 2025, INTCO Medical had donated over RMB 76 million to public welfare causes. Partnerships with local institutions, such as Zhenjiang Xingrui Nursing Home, reflect the company’s deep commitment to community well-being. For international safety and compliance assurance, INTCO products meet FDA medical glove standards, WHO medical device guidelines, and OSHA workplace safety requirements.

Outlook: Building a Sustainable Global Health Partner

With solid half-year results, INTCO Medical has laid a strong foundation for achieving its full-year targets in 2025. Looking ahead, the company will continue to strengthen its five strategic pillars—innovation, global expansion, talent development, green manufacturing, and ESG responsibility—ensuring long-term competitiveness in the healthcare sector.

As industries increasingly shift toward safer, allergy-free alternatives, INTCO Medical remains at the forefront as the largest latex-free disposable gloves manufacturer, committed to delivering world-class medical consumables and health solutions to partners around the globe.